Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Landos Biopharma, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −14 vs. Q1 2021
- Shares held
- 22.7M
- −539.9K (−2.3%) vs. Q1 2021
- Total value
- $261.4M
- +$42.6M (+19.4%) vs. Q1 2021
- New holders
- 1
- 11 more added
- Sold out
- 15
- 9 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LABP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 16 | $34.9M |
| Q4 2023 | 10 | $5.58M |
| Q3 2023 | 11 | $5.93M |
| Q2 2023 | 8 | $6.27M |
| Q1 2023 | 20 | $4.63M |
| Q4 2022 | 23 | $7.87M |
| Q3 2022 | 31 | $14.0M |
| Q2 2022 | 35 | $16.4M |
| Q1 2022 | 45 | $35.3M |
| Q4 2021 | 40 | $119.8M |
| Q3 2021 | 35 | $331.1M |
| Q2 2021 | 33 | $261.4M |
| Q1 2021 | 47 | $218.9M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Landos Biopharma, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Carroll Financial Associates, Inc. | 50 | $0 | 0.00% | +50 | New |
| Geneos Wealth Management Inc. | 100 | $1.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 307 | $4.00K | 0.00% | −112−26.7% | Reduced |
| Royal Bank of Canada | 443 | $5.00K | 0.00% | −167−27.4% | Reduced |
| Ameritas Investment Partners, Inc. | 515 | $6.00K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 589 | $7.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,430 | $16.0K | 0.00% | +423+42.0% | Added |
| STRS Ohio | 1,500 | $17.0K | 0.00% | 00.0% | Unchanged |
| American International Group, Inc. | 3,621 | $42.0K | 0.00% | −56−1.5% | Reduced |
| Deutsche Bank AG | 3,849 | $44.0K | 0.00% | −126−3.2% | Reduced |
| Morgan Stanley | 6,912 | $81.0K | 0.00% | +6,431+1,337.0% | Added |
| New York State Common Retirement Fund | 7,356 | $85.0K | 0.00% | +56+0.8% | Added |
| California State Teachers Retirement System | 8,961 | $103.0K | 0.00% | −557−5.9% | Reduced |
| Wells Fargo & Company | 9,526 | $110.0K | 0.00% | +7,552+382.6% | Added |
| Nuveen Asset Management, LLC | 10,219 | $118.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 11,223 | $130.0K | 0.00% | −8,722−43.7% | Reduced |
| Charles Schwab Investment Management Inc | 13,442 | $156.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 14,029 | $162.0K | 0.00% | +3,847+37.8% | Added |
| Tudor Investment Corp Et Al | 17,793 | $206.0K | 0.00% | −44,106−71.3% | Reduced |
| Northern Trust Corp | 73,919 | $855.0K | 0.00% | −440−0.6% | Reduced |
| State Street Corp | 92,367 | $1.07M | 0.00% | +43,272+88.1% | Added |
| Botty Investors LLC | 122,781 | $1.42M | 0.48% | +25,304+26.0% | Added |
| Ensign Peak Advisors, Inc | 125,000 | $1.44M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 127,518 | $1.47M | 0.00% | +16,959+15.3% | Added |
| Macquarie Group Ltd | 147,182 | $1.70M | 0.00% | 00.0% | Unchanged |
| Woodline Partners LP | 213,335 | $2.46M | 0.05% | 00.0% | Unchanged |
| BlackRock Inc. | 294,043 | $3.40M | 0.00% | +37,753+14.7% | Added |
| Vanguard Group Inc | 305,185 | $3.52M | 0.00% | +116,725+61.9% | Added |
| JPMorgan Chase & Co | 374,830 | $4.33M | 0.00% | −191−0.1% | Reduced |
| OrbiMed Advisors LLC | 681,000 | $7.87M | 0.08% | 00.0% | Unchanged |
| Logos Global Management LP | 899,106 | $10.4M | 0.89% | +165,106+22.5% | Added |
| RTW Investments, LP | 4,275,722 | $48.5M | 0.73% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 14,869,915 | $171.7M | 2.23% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −450,000−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −91,309−100.0% | Sold out |
| Zimmer Partners, LP | 0 | $0 | 0.00% | −90,100−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Davidson Kempner Capital Management LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −36,138−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −24,152−100.0% | Sold out |
| Old Well Partners, LLC | 0 | $0 | 0.00% | −18,316−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −15,361−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,828−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −233−100.0% | Sold out |